Skip to main content
M. Adel Aslani-Far

Adel Aslani-Far focuses his practice on cross-border and domestic public company mergers and acquisitions, corporate governance, and shareholder activism and takeover defense. He counsels large multinational corporations on negotiated and hostile public M&A transactions, as well as a broad range of private acquisitions and joint ventures around the world. He also regularly counsels public company boards, board committees. and senior management on corporate governance and strategic planning, including shareholder activism and takeover defense preparedness and in defending against proxy contests and negotiating settlements with many of the most prominent activist funds. In addition, Mr. Aslani-Far has deep experience advising special committees of boards of directors in conflict of interest transactions.

In 2018, he was selected as a member of The Legal 500 US Hall of Fame for his M&A work, one of 14 M&A attorneys recognized for “constant praise by their clients for continued excellence.”

Concentrations

  • Cross-border and domestic public company M&A
  • Takeover defense
  • Shareholder activism defense
  • Private acquisitions
  • Joint ventures

Expertise

Erfahrung

Mr. Aslani-Far's representative M&A transactions include advising:

  • Siemens AG in the acquisitions of:
    • Dresser-Rand Group°
    • Mentor Graphics Corp.°
  • Safeway Inc. in its acquisition by a consortium led by Cerberus Capital Management and Albertsons.°
  • Scripps Networks Interactive in the acquisition of TVN SA, Poland’s premiere media company.°
  • Sorin S.p.A. in its cross-border merger with Cyberonics Inc.°
  • The Walt Disney Company in numerous transactions including:
    • acquisition of Maker Studios°
    • acquisition of Playdom Inc.°
    • acquisition of Fox Family Worldwide°
    • reverse Morris Trust tax-free divestiture of its ABC Radio business°
    • creation of, and ultimate exit from, the E! Channel Entertainment joint venture with Comcast Corporation°
  • Energy Capital Partners in its acquisition of Calpine Corporation.°
  • Ares Capital in connection with its acquisition of American Capital, a publicly traded private equity firm and asset manager with $20 billion of assets under management.°
  • Eli Lilly and Company in numerous transactions, including:
    • acquisition of ImClone Systems°
    • acquisition of ICOS Corp.°
    • acquisition of Johnson & Johnson’s animal health business°
    • acquisition of Alnara Pharmaceuticals°
    • acquisition of a portfolio of animal health products from Pfizer and Wyeth°
    • acquisition of Monsanto Company’s animal health business°
    • equity investment in United Therapeutics Corp.°
    • acquisition of Hypnion°
    • acquisition of Applied Molecular Evolution°
  • Royal DSM N.V. in numerous transactions, including:
    • a joint venture with JLL Partners to form DPx Holdings B.V., a global leader in pharmaceutical contract development/manufacturing°
    • multiple equity investments in Amyris°
  • The Special Committee of the Board of Directors of Athene Holding Ltd. in connection with Athene’s reinsurance of $19 billion of fixed and fixed index annuities of Voya Financial.°
  • Qatar Investment Authority in its strategic alliance with NYSE Euronext for an integrated cash and derivatives exchange in Qatar.°
  • Rakuten Inc. in numerous transactions, including:
    • acquisition of Deep Forest Media°
    • acquisition of Viki Inc.°
    • equity investment in Daily Grommet°
  • Booz Allen Hamilton in the sale of a majority interest in its US Government Business to Carlyle Group.°
  • Books-a-Million in the take-private transaction by the Anderson family.°
  • Asian Food Channel, an Asia-based provider of food and lifestyle television programming, in its sale to Scripps Networks Interactive.°
  • Body Central in its recapitalization.°
  • GTCR in its acquisition of Protection One, Inc.°
  • Thoratec Corporation in the proposed sale of its International Technidyne subsidiary to Danaher Corporation.°
  • Ratos AB of Sweden in the sale of two US operating subsidiaries to 3D Systems Corporation.°
  • GSO Capital Partners in its acquisition of Energy Alloys.°
  • Sony Corporation in numerous transactions, including:
    • consortium acquisition (with Providence Equity, Comcast Corporation, and others) of Metro-Goldwyn-Mayer°
    • acquisition of InterTrust Technologies Corporation°
  • Novartis AG in numerous transactions, including:
    • acquisition of worldwide rights to Famvir® from GlaxoSmithKline plc°
    • acquisition of 51% of Idenix Pharmaceuticals°
    • sale of Brethine® to Neosan Pharmaceuticals and Aaipharma°
  • Zimmer Holdings in the unsolicited cross-border acquisitions of Centerpulse AG and Incentive Capital AG, the first-ever hostile transaction in Switzerland.°
  • ACH Food Companies in its acquisition of Mazola® and related brands from Unilever.°
  • Talbots in its acquisition of J.Jill.°
  • Arrow Financial Services in the sale of a majority interest to Sallie Mae.°
  • The Ackerley Group in its acquisition by Clear Channel Communications.°
  • Major investment banking firms acting as financial advisors in numerous transactions, including:
    • Morgan Stanley and LionTree advising the Special Committee of Viacom in the CBS/Viacom merger°
    • Evercore advising Whole Foods in its activism defense against Jana Partners and its acquisition by Amazon.°

Mr. Aslani-Far has counseled numerous public company clients on activism preparedness and responses to publicly disclosed campaigns and private approaches by many of the most prominent activist funds, including Elliott Management, Engaged Capital, GAMCO Investors, Icahn Associates, JANA Partners, Raging Capital, Starboard Value and Steel Partners. He has deep experience in defending against proxy contests and in negotiating settlements with activists.°

°The above representations were handled by Mr. Aslani-Far prior to his joining Greenberg Traurig, LLP.

Anerkennung durch den Markt

  • Listed, Chambers Global, Corporate M&A (International & Cross-Border) USA, 2020 
  • The Legal 500 US
    • “Leading Lawyer” for M&A Mega-Deals (US$5 billion plus), M&A Large Deals (US$1 billion plus) and Shareholder Activism Defense, 2012-2019
    • “Hall of Fame, United States M&A/Corporate and Commercial - M&A: Large Deals ($1bn+) ” 2018
  • Recognized as a “Leading Lawyer” for New York Corporate/M&A, Chambers USA, 2006-2019
  • Listed, Super Lawyers magazine, “New York Metro Super Lawyers,” 2008-2019
  • Recognized, The National Law Journal, “Mergers & Acquisitions and Antitrust Trailblazers,” 2015
  • Member, Association of the Bar of the City of New York, 2010-Present
    • Committee on Mergers, Acquisitions and Corporate Control Contests, 2010-Present
  • Member, American Bar Association

Ausbildung

Akademische Ausbildung
  • J.D., Georgetown University, 1993
  • A.B., Columbia University, 1990
Zulassung
  • New York